Navigation Links
Induced Labor May Improve Outcome in Risky Pregnancies
Date:8/3/2009

Delivery at 37 weeks helps women with hypertensive disorders, study finds

MONDAY, Aug. 3 (HealthDay News) -- Labor should be induced after 37 weeks in pregnant women with mild hypertension disorders such as high blood pressure and mild preeclampsia, according to a new study in The Lancet.

The study included 756 pregnant women in the Netherlands. All had been pregnant 36 to 41 weeks and had gestational hypertension or mild preeclampsia. Some of the women underwent induced labor and others were monitored as their pregnancies continued.

The two groups were compared on a number of measures that the researchers labeled as poor maternal outcome, including death, eclampsia, pulmonary edema, progression to severe high blood pressure, major post-birth bleeding (loss of a liter or more of blood), and what's known as HELLP syndrome (hemolysis, elevated liver enzymes and low platelet, or red blood cell, count).

Poor maternal outcome occurred in 31 percent of the women who had induced labor and in 44 percent who were monitored. For women who had induced labor, that equated to a 29 percent lower risk for developing poor maternal outcome than those who were monitored, the study reported.

The findings appear online Aug. 3 in The Lancet.

The researchers also found that women who had induced labor had fewer cesarean sections than those in the monitored group.

"The results of our trial are important for both developed countries in which induction of labor in women with hypertensive disease beyond 36 weeks' gestation has been controversial, and for developing countries in which maternal morbidity and mortality rates are substantially increased," wrote Dr. Corine M. Koopmans, of the University Medical Centre Groningen, and colleagues.

"Our finding that induction of labor was associated with a reduced risk of severe hypertension or HELLP syndrome and subsequent need for cesarean se
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. 1 in 3 Varsity Athletes Has Exercise-Induced Asthma
3. Allergy-Induced Asthma More Common in Affluent Countries
4. Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does
5. Clemson awarded $2M to study radiation-induced bone loss
6. Parkinsons Institute research shows that nicotine reduces levodopa-induced dyskinesias
7. Epilepsy-induced brain cell damage prevented in the laboratory
8. Scientists identify gene responsible for statin-induced muscle pain
9. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
10. A promising new approach to cadmium induced hepatoxicity: Cytoprotective effect of midkine
11. Weight gain induced by antipsychotic drugs can be avoided
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Induced Labor May Improve Outcome in Risky Pregnancies
Induced Labor May Improve Outcome in Risky Pregnancies
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Within3 Expands into Mobile Applications 2Congressman Fattah Supports Legislation to Address More Funds for Pancreatic Cancer Research 60857 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 2Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Ophthalmic Solution 6058 2